Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
650 Pleasant Street , Watertown, MA, 02472, US
Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.
By: Kristin Brooks
Biotech companies partner to develop low-dose, targeted AAV gene therapies for cardiac disease.
By: Charlie Sternberg
Reaffirms its strategic focus on manufacturing essential components such as cytokines and growth factors used in novel cell and gene therapies.
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
By: Adam Tuszyner
Released By Solvias
Suitable for storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency medications.
Adverum is developing a pipeline of intravitreal single-administration gene therapies with the aspiration of developing functional cures to restore vision and prevent blindness.
As the demand for cell and gene therapies continues to grow around the world, Cryoport Systems is investing in infrastructure, talent, and technology to deliver seamless support across geographical borders.
Released By Cryoport Systems
Agreement allows Andelyn to use Stanton Lab CNS capsids to perform R&D services for clients developing gene therapies.
Aim to develop and commercialize RGX-121 and RGX-111 for MPS diseases.
Will support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex vivo cell and gene therapies.
Aim to address the high manufacturing costs associated with AAV production and make gene therapies more accessible to patients.
Partnership will support the development of cell and gene therapies and mRNA-based treatments.
Will highlight new solutions for single-use bioprocessing, cell & gene therapies and more.
Cryoport will support SK pharmteco's manufacture of APIs and intermediates, biopharmaceuticals, and cell and gene therapies.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
